SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics (CVKD) is trending due to recent pipeline expansion with VLX-1005 for heparin-induced thrombocytopenia and ongoing progress for its lead candidate tecarfarin, including manufacturing readiness and a collaboration with Abbott for its Phase 3 trial. The community is sharply divided, with bulls highlighting the potential for a "warfarin replacement" and analyst price targets, while skeptics point to cash burn concerns, dilution risk, and accusations of bot-driven pumping.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is trending after the U.S. government announced a significant investment, including a substantial equity stake and a loan, to bolster the domestic rare earth supply chain. The news has ignited strong bullish sentiment within the community, with widespread discussion around potential valuation impacts and the possibility of a short squeeze. This development also highlights the broader sector's strategic importance amid a global push for critical mineral independence and robust "mine-to-magnet" capabilities.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is actively trending as its price hovers around key support, with the community dissecting the impact of a reported 2.05 million LTC being moved off exchanges and subsequently sold, which many attribute to recent price action. Bulls are accumulating, viewing current levels as a significant undervaluation and a prime entry point ahead of potential regulatory clarity, while bears aggressively short, citing long-term underperformance against other digital assets. This divergence in sentiment fuels intense debate over perceived market manipulation and the asset's future trajectory.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidia Corp. is trending on the back of stellar preliminary Q4 YUTREPIA sales, which significantly exceeded expectations and led to early profitability and positive cash flow. The community is buzzing about the rapid patient uptake and multiple analyst upgrades, anticipating further upside. Much conversation also centers on a highly awaited patent litigation ruling, with many expecting a favorable outcome for Liquidia to clear a major overhang.

The PNC Financial Services Group, Inc. is a holding company, which engages in the provision of financial services. It operates through the following segments: Retail Banking, Corporate and Institutional Banking, Asset Management Group, and Other. The Retail Banking segment offers deposit, lending, brokerage, investment management, and cash management products and services to consumer and small business customers. The Corporate and Institutional segment covers the lending, treasury management, and capital markets-related products and services to mid-sized and large corporations, government, and not-for-profit entities. The Asset Management Group segment includes personal wealth management for high net worth and ultra-high net worth clients and institutional asset management. The company was founded in 1983 and is headquartered in Pittsburgh, PA.

PNC Financial Services Group Inc

PNC Financial Services Group

PNC Financial Services is trending following strong quarterly earnings, which is driving community discussion around the stock nearing all-time highs. This optimism is fueled by recent analyst upgrades and technical analysis suggesting further upside. Investors are also noting PNC's strategic expansion, including geographic acquisitions and a partnership to offer digital asset trading.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance (AERO) is trending following its recent listing on Robinhood, sparking conversations around easy payday opportunities and its pivotal role as Base's central liquidity hub. The community is actively debating AERO's strong fundamentals, including significant protocol revenue and a strategic merger with Velodrome, which many believe positions it as a key player in the evolving DeFi landscape. Despite recent market volatility, there's high conviction among many, anticipating substantial growth as the Base ecosystem expands.

BitGo Holdings, Inc. provides cryptocurrency custody solutions. It offers self-custody wallet, qualified custody, liquidity and prime, and infrastructure-as-a-service. The company was founded by Michael Belshe in 2013 and is headquartered in Palo Alto, CA.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo's recent NYSE debut as a crypto infrastructure IPO has triggered a polarized community reaction, with many investors dismayed by its rapid post-listing decline and labeling it a "scam" or "busted IPO" akin to other volatile crypto plays. Despite the heavy selling pressure, a segment of the community remains bullish, emphasizing its profitable institutional custody business, significant assets under management, and unique market position as potential drivers for a future rebound.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne (S) is trending following its recent earnings report, which, despite strong revenue growth and improved profitability, led to a notable stock drop, with conservative guidance being a key point of community discussion. Investors are actively debating whether the stock is severely undervalued in the growing cybersecurity sector, frequently pointing to its robust balance sheet and expressing hopes for a potential acquisition. Much of the conversation reflects a strong belief in the company's long-term potential contrasting with its current low valuation, fueling speculation about market manipulation.

Zoracles

Zoracles ($ZORA) is buzzing with community anticipation for a significant reversal and "pump," as many actively accumulate the crypto asset. Investors are keenly watching for potential upside driven by its role in the creator economy and broader market catalysts, such as the impending Clarity Act, expected to enhance adoption and liquidity across the crypto space. This underlying optimism fuels discussions about ZORA's potential for substantial price movement independent of Bitcoin's immediate direction.

Decentraland

Decentraland ($MANA) is trending amid fervent community debate over a potential metaverse resurgence, fueled by persistent rumors of major tech giant partnerships and signals of broader whale accumulation in the Web3 gaming sector. While many anticipate a significant rally for metaverse projects, a vocal group remains skeptical, dismissing MANA as a past hype cycle token with limited current utility. The broader crypto market is observing if this signals an impending "Altcoin Season" for the sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 7.6% - Here's What Happened

Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 7.6% - Time to Sell...

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Gap Down - Time to Sell?

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Gap Down - Here's Why...

Phathom Pharma Shows Sales Strength, Targets 2026 Profitability

Phathom Pharmaceuticals (NASDAQ: PHAT) reported Q4 sales of $57-$58 million, updated FY2025 revenue guidance to $174.5-$175.5 million.read more...

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine research firms that are covering the stock, MarketBeat...

Simplify Asset Management Inc. Reduces Position in Phathom Pharmaceuticals, Inc. $PHAT

Simplify Asset Management Inc. reduced its position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Free Report) by 38.3% during the third quarter, according to its most recent filing with the...

Notable Monday Option Activity: PHAT, WHR, QBTS

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Phathom Pharmaceuticals Inc (Symbol: PHAT), where a total of 5,492 contracts have traded...

Raymond James Financial Begins Coverage on Phathom Pharmaceuticals (NASDAQ:PHAT)

Raymond James Financial began coverage on Phathom Pharmaceuticals in a research report on Thursday. They issued a "strong-buy" rating and a $28.00 target price on the stock...

Frazier Life Sciences Management L.P. Purchases 2,357,210 Shares of Phathom Pharmaceuticals, Inc. $PHAT

Frazier Life Sciences Management L.P. lifted its holdings in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Free Report) by 23.3% in the 2nd quarter, according to the company in its most...

Phathom Pharmaceuticals (NASDAQ:PHAT) Reaches New 12-Month High - What's Next?

Phathom Pharmaceuticals (NASDAQ:PHAT) Hits New 52-Week High - Here's What Happened...

683 Capital Management LLC Grows Stock Position in Phathom Pharmaceuticals, Inc. $PHAT

683 Capital Management LLC grew its position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Free Report) by 45.7% during the 2nd quarter, according to the company in its most recent disclosure with...

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.42	--	--	N/A
Q3 '25	-$0.46	-$0.41	11.44%	BEAT
Q2 '25	-$0.95	-$1.05	-10.53%	MISSED
Q1 '25	-$1.10	-$1.31	-18.82%	MISSED
Q4 '24	-$1.21	-$1.05	13.58%	BEAT

PHAT
Phathom Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest PHAT News

PHATPhathom Pharmaceuticals Inc